Phio Historical Financial Ratios
| PHIO Stock | USD 2.64 0.13 5.18% |
Phio Pharmaceuticals is promptly reporting on over 98 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Book Value Per Share of 35.14, Invested Capital of 0.0, Average Payables of 0.0 or Stock Based Compensation To Revenue of 21.55 will help investors to properly organize and evaluate Phio Pharmaceuticals Corp financial condition quickly.
Phio |
About Phio Financial Ratios Analysis
Phio Pharmaceuticals CorpFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Phio Pharmaceuticals investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Phio financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Phio Pharmaceuticals history.
Phio Pharmaceuticals Financial Ratios Chart
Add Fundamental
Price To Sales Ratio
Price to Sales Ratio is figured by comparing Phio Pharmaceuticals Corp stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Phio Pharmaceuticals sales, a figure that is much harder to manipulate than other Phio Pharmaceuticals Corp multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.Dividend Yield
Dividend Yield is Phio Pharmaceuticals Corp dividend as a percentage of Phio Pharmaceuticals stock price. Phio Pharmaceuticals Corp dividend yield is a measure of Phio Pharmaceuticals stock productivity, which can be interpreted as interest rate earned on an Phio Pharmaceuticals investment. A financial ratio that shows how much a company pays out in dividends each year relative to its stock price, calculated as annual dividends per share divided by price per share.Payables Turnover
A liquidity ratio that shows how quickly a company pays off its suppliers by dividing total purchases by average accounts payable.Capex To Revenue
The ratio of a company's capital expenditures to its total revenue, indicating how much of the revenue is used for acquiring or maintaining physical assets.Most ratios from Phio Pharmaceuticals' fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Phio Pharmaceuticals Corp current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Phio Pharmaceuticals Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. At this time, Phio Pharmaceuticals' EV To Free Cash Flow is very stable compared to the past year. As of the 29th of November 2024, Tangible Book Value Per Share is likely to grow to 35.14, while PTB Ratio is likely to drop 0.19.
| 2023 | 2024 (projected) | Dividend Yield | 0.009639 | 0.009157 | Price To Sales Ratio | 185.55 | 274.78 |
Phio Pharmaceuticals fundamentals Correlations
Click cells to compare fundamentals
Phio Pharmaceuticals Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Phio Pharmaceuticals fundamentals Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Ptb Ratio | 0.75 | 0.95 | 0.58 | 0.47 | 0.2 | 0.19 | |
| Book Value Per Share | 1.3K | 306.77 | 184.79 | 85.91 | 33.46 | 35.14 | |
| Free Cash Flow Yield | (2.01) | (0.72) | (0.93) | (2.42) | (6.81) | (7.15) | |
| Operating Cash Flow Per Share | (2.0K) | (207.44) | (99.91) | (96.14) | (46.53) | (48.86) | |
| Capex To Depreciation | 1.07 | 0.26 | 0.68 | 0.63 | 0.0272 | 0.0258 | |
| Pb Ratio | 0.75 | 0.95 | 0.58 | 0.47 | 0.2 | 0.19 | |
| Free Cash Flow Per Share | (2.0K) | (207.89) | (100.34) | (97.1) | (46.55) | (48.88) | |
| Roic | (1.52) | (0.65) | (0.61) | (1.03) | (1.39) | (1.32) | |
| Net Income Per Share | (2.1K) | (207.25) | (111.32) | (89.61) | (46.87) | (49.21) | |
| Payables Turnover | 7.87 | 0.005315 | 0.25 | 0.68 | 9.64 | 18.38 | |
| Cash Per Share | 1.6K | 335.69 | 202.7 | 93.38 | 36.75 | 34.92 | |
| Pocfratio | (0.31) | (0.5) | (1.4) | (1.08) | (0.42) | (0.15) | |
| Capex To Operating Cash Flow | (0.008329) | (0.002159) | (0.004301) | (0.009976) | (4.65E-4) | (4.88E-4) | |
| Pfcf Ratio | (0.31) | (0.5) | (1.4) | (1.08) | (0.41) | (0.15) | |
| Days Payables Outstanding | 68.7K | 1.5K | 537.99 | 1.5K | 37.87 | 35.98 | |
| Income Quality | 0.97 | 1.0 | 0.89 | 1.06 | 0.99 | 0.66 | |
| Roe | (1.54) | (0.68) | (0.6) | (1.04) | (1.4) | (1.33) | |
| Ev To Operating Cash Flow | 0.24 | 0.14 | 0.92 | 0.53 | 0.64 | 0.67 | |
| Pe Ratio | (0.32) | (0.49) | (1.4) | (0.97) | (0.45) | (0.15) | |
| Return On Tangible Assets | (1.1) | (0.56) | (0.52) | (0.88) | (1.16) | (1.21) | |
| Ev To Free Cash Flow | 0.24 | 0.14 | 0.92 | 0.52 | 0.64 | 0.67 | |
| Earnings Yield | (2.04) | (0.71) | (1.03) | (2.23) | (6.85) | (7.19) | |
| Net Debt To E B I T D A | 0.72 | 1.56 | 1.82 | 1.02 | 0.79 | 0.74 | |
| Current Ratio | 3.88 | 6.91 | 8.06 | 6.9 | 5.71 | 4.29 | |
| Tangible Book Value Per Share | 1.3K | 306.77 | 184.79 | 85.91 | 33.46 | 35.14 | |
| Graham Number | 7.9K | 1.2K | 680.33 | 416.18 | 187.85 | 178.45 | |
| Shareholders Equity Per Share | 1.3K | 306.77 | 184.79 | 85.91 | 33.46 | 35.14 | |
| Capex Per Share | 16.89 | 0.45 | 0.43 | 0.96 | 0.0216 | 0.0206 | |
| Graham Net Net | 1.1K | 271.54 | 175.42 | 77.72 | 29.68 | 31.16 | |
| Enterprise Value Over E B I T D A | 0.23 | 0.15 | 0.84 | 0.57 | 0.65 | 0.68 |
Pair Trading with Phio Pharmaceuticals
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Phio Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Phio Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.Moving against Phio Stock
| 0.54 | ESPR | Esperion Therapeutics | PairCorr |
| 0.52 | VTRS | Viatris | PairCorr |
| 0.52 | BMY | Bristol Myers Squibb Aggressive Push | PairCorr |
| 0.38 | EBS | Emergent Biosolutions | PairCorr |
The ability to find closely correlated positions to Phio Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Phio Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Phio Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Phio Pharmaceuticals Corp to buy it.
The correlation of Phio Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Phio Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Phio Pharmaceuticals Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Phio Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Phio Pharmaceuticals Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Phio Pharmaceuticals. If investors know Phio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Phio Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (14.81) | Return On Assets (0.61) | Return On Equity (1.27) |
The market value of Phio Pharmaceuticals Corp is measured differently than its book value, which is the value of Phio that is recorded on the company's balance sheet. Investors also form their own opinion of Phio Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Phio Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Phio Pharmaceuticals' market value can be influenced by many factors that don't directly affect Phio Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Phio Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Phio Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Phio Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.